As organizations rapidly adopt generative AI (GenAI) technologies, public companies face increasing pressure to manage new and evolving risks while maintaining strong internal controls and governance.
Join RSM for this recorded webinar as we break down newly released GenAI guidance from the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and explore how it applies specifically to public company environments.
In this recorded session, we will discuss how to integrate GenAI into existing internal control frameworks; how to address key risk areas including data integrity, model governance and regulatory scrutiny; and how to align with the Sarbanes-Oxley Act and broader enterprise risk management programs. We'll also explore how leaders across internal audit, risk, finance and compliance can responsibly scale GenAI initiatives while maintaining control effectiveness and stakeholder confidence.
